273 related articles for article (PubMed ID: 28745687)
21. Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan.
Ito N; Hataya H; Saida K; Amano Y; Hidaka Y; Motoyoshi Y; Ohta T; Yoshida Y; Terano C; Iwasa T; Kubota W; Takada H; Hara T; Fujimura Y; Ito S
Clin Exp Nephrol; 2016 Apr; 20(2):265-72. PubMed ID: 26156042
[TBL] [Abstract][Full Text] [Related]
22. Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients.
Rudoni J; Jan A; Hosing C; Aung F; Yeh J
Eur J Haematol; 2018 Sep; 101(3):389-398. PubMed ID: 29920784
[TBL] [Abstract][Full Text] [Related]
23. Treatment of thrombotic microangiopathies with plasma exchange.
Basic-Jukic N; Kes P; Bubic-Filipi L; Brunetta B
Hematology; 2007 Feb; 12(1):63-7. PubMed ID: 17364995
[TBL] [Abstract][Full Text] [Related]
24. Bevacizumab-Associated Thrombotic Microangiopathy Treated with Eculizumab: A Case Report.
Padilha WSC; Cesar BN; Pacheco ST; De Sousa AA; Ledesma FL; Malheiros DMAC; Teixeira MCA
Am J Case Rep; 2023 Aug; 24():e940906. PubMed ID: 37644709
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of eculizumab in a case of pregnancy-associated aHUS].
Cravero R; Ardissino G; Colageo U; Staffa P; Bruschetta E; Maroni S; Karvela E; Spagarino E; Ruggeri V; Jura R
G Ital Nefrol; 2016; 33(4):. PubMed ID: 27545639
[TBL] [Abstract][Full Text] [Related]
26. Differential diagnosis of thrombotic microangiopathy in nephrology.
Sakari Jokiranta T; Viklicky O; Al Shorafa S; Coppo R; Gasteyger C; Macia M; Pankratenko T; Shenoy M; Soylemezoglu O; Tsimaratos M; Wetzels J; Haller H
BMC Nephrol; 2017 Oct; 18(1):324. PubMed ID: 29080561
[TBL] [Abstract][Full Text] [Related]
27. Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
Guzzo G; Kissling S; Pantaleo G; Pascual M; Sadallah S; Teta D
BMC Nephrol; 2021 Jul; 22(1):252. PubMed ID: 34229609
[TBL] [Abstract][Full Text] [Related]
28. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
[TBL] [Abstract][Full Text] [Related]
29. Short Course of Eculizumab May Be Effective in Dialysis-Dependent Transplantation-Associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: A Case Report.
Jarmoliński T; Rosa M; Puziewicz-Zmonarska A; Kałwak K
Transplant Proc; 2020 Oct; 52(8):2544-2547. PubMed ID: 32917392
[TBL] [Abstract][Full Text] [Related]
30. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
[TBL] [Abstract][Full Text] [Related]
31. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
[TBL] [Abstract][Full Text] [Related]
32. Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient.
Kaneda T; Tanaka E; Akutsu Y; Kanamori T; Mouri M; Morio T; Mori M
CEN Case Rep; 2020 Nov; 9(4):301-307. PubMed ID: 32304042
[TBL] [Abstract][Full Text] [Related]
33. Thrombotic Microangiopathy: A Multidisciplinary Team Approach.
Gordon CE; Chitalia VC; Sloan JM; Salant DJ; Coleman DL; Quillen K; Ravid K; Francis JM
Am J Kidney Dis; 2017 Nov; 70(5):715-721. PubMed ID: 28720207
[TBL] [Abstract][Full Text] [Related]
34. Pregnancy-related thrombotic microangiopathies: Clues from complement biology.
Fakhouri F
Transfus Apher Sci; 2016 Apr; 54(2):199-202. PubMed ID: 27158062
[TBL] [Abstract][Full Text] [Related]
35. Thrombotic microangiopathies in critically ill children: The MATUCIP registry in Spain.
Bermúdez Barrezueta L; Belda Hofheinz S; Martínez De Azagra Garde A; Bobillo Pérez S; Nieto Faza M; Rodríguez Núñez A;
An Pediatr (Engl Ed); 2023 Mar; 98(3):194-203. PubMed ID: 36842880
[TBL] [Abstract][Full Text] [Related]
36. Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma.
Rassner M; Baur R; Wäsch R; Schiffer M; Schneider J; Mackensen A; Engelhardt M
BMC Nephrol; 2021 Jan; 22(1):32. PubMed ID: 33461512
[TBL] [Abstract][Full Text] [Related]
37. Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy.
Gloude NJ; Dandoy CE; Davies SM; Myers KC; Jordan MB; Marsh RA; Kumar A; Bleesing J; Teusink-Cross A; Jodele S
J Clin Immunol; 2020 Jul; 40(5):699-707. PubMed ID: 32447592
[TBL] [Abstract][Full Text] [Related]
38. Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort.
Aigner C; Gaggl M; Stemer G; Eder M; Böhmig G; Kain R; Prohászka Z; Garam N; Csuka D; Sunder-Plassmann R; Piggott LC; Haninger-Vacariu N; Schmidt A; Sunder-Plassmann G
J Nephrol; 2022 Mar; 35(2):451-461. PubMed ID: 33599971
[TBL] [Abstract][Full Text] [Related]
39. Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome.
Geethakumari PR; Mille P; Gulati R; Nagalla S
Transfus Apher Sci; 2017 Jun; 56(3):400-403. PubMed ID: 28428030
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
Riedl M; Fakhouri F; Le Quintrec M; Noone DG; Jungraithmayr TC; Fremeaux-Bacchi V; Licht C
Semin Thromb Hemost; 2014 Jun; 40(4):444-64. PubMed ID: 24911558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
